BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11336923)

  • 1. Maintenance of vertebral body bone mass and strength created by human parathyroid hormone treatment in ovariectomized rats.
    Samnegård E; Akhter MP; Recker RR
    Bone; 2001 Apr; 28(4):414-22. PubMed ID: 11336923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
    Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
    Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of cortical bone in human parathyroid hormone(1-84)-treated ovariectomized rats.
    Samnegård E; Iwaniec UT; Cullen DM; Kimmel DB; Recker RR
    Bone; 2001 Mar; 28(3):251-60. PubMed ID: 11248654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
    Rhee Y; Won YY; Baek MH; Lim SK
    J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
    Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
    J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V; Birchman R; Wu DD; Lindsay R
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength--assessed in a sexually mature, ovariectomized rat model.
    Mosekilde L; Danielsen CC; Søgaard CH; McOsker JE; Wronski TJ
    Bone; 1995 Feb; 16(2):223-30. PubMed ID: 7756051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of two anabolic agents (fluoride and PTH) on ash density and bone strength assessed in an osteopenic rat model.
    Søgaard CH; Mosekilde L; Thomsen JS; Richards A; McOsker JE
    Bone; 1997 May; 20(5):439-49. PubMed ID: 9145241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of maintenance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat.
    Hodsman AB; Watson PH; Drost D; Holdsworth D; Thornton M; Hock J; Bryant H; Fraher LJ
    Bone; 1999 May; 24(5):451-5. PubMed ID: 10321904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The addition of a raloxifene analog (LY117018) allows for reduced PTH(1-34) dosing during reversal of osteopenia in ovariectomized rats.
    Hodsman AB; Drost D; Fraher LJ; Holdsworth D; Thornton M; Hock J; Bryant H; Watson PH
    J Bone Miner Res; 1999 May; 14(5):675-9. PubMed ID: 10320515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anabolic effects of recombinant human parathyroid hormone (1 - 84) and synthetic human parathyroid hormone (1 - 34) on the mandibles of osteopenic ovariectomized rats with maxillary molar extraction.
    Kawane T; Takahashi S; Saitoh H; Okamoto H; Kubodera N; Horiuchi N
    Horm Metab Res; 2002 Jun; 34(6):293-302. PubMed ID: 12173069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats.
    Mosekilde L; Danielsen CC; Gasser J
    Endocrinology; 1994 May; 134(5):2126-34. PubMed ID: 8156913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTH has a more pronounced effect on vertebral bone mass and biomechanical competence than antiresorptive agents (estrogen and bisphosphonate)--assessed in sexually mature, ovariectomized rats.
    Mosekilde L; Søgaard CH; McOsker JE; Wronski TJ
    Bone; 1994; 15(4):401-8. PubMed ID: 7917578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a weekly injection of human parathyroid hormone (1-34) and withdrawal on bone mass, strength, and turnover in mature ovariectomized rats.
    Okimoto N; Tsurukami H; Okazaki Y; Nishida S; Sakai A; Ohnishi H; Hori M; Yasukawa K; Nakamura T
    Bone; 1998 May; 22(5):523-31. PubMed ID: 9600787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats.
    Ma YL; Bryant HU; Zeng Q; Schmidt A; Jee WS; Sato M
    J Bone Miner Metab; 2005; 23 Suppl():62-8. PubMed ID: 15984416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stimulation of vertebral and tibial bone growth by the parathyroid hormone fragments, hPTH-(1-31)NH2, [Leu27]cyclo(Glu22-Lys26)hPTH-(1-31)NH2, and hPTH-(1-30)NH2.
    Whitfield JF; Morley P; Fraher L; Hodsman AB; Holdsworth DW; Watson PH; Willick GE; Barbier JR; Gulam M; Isaacs RJ; MacLean S; Ross V
    Calcif Tissue Int; 2000 Apr; 66(4):307-12. PubMed ID: 10742450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of parathyroid hormone (hPTH[1-84]) treatment on bone mass and strength in ovariectomized rats.
    Akhter MP; Kimmel DB; Recker RR
    J Clin Densitom; 2001; 4(1):13-23. PubMed ID: 11309515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of age, estrogen depletion, and parathyroid hormone treatment on vertebral cancellous wall width in female rats.
    Wronski TJ; Pun S; Liang H
    Bone; 1999 Oct; 25(4):465-8. PubMed ID: 10511114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.